{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:20:12Z","timestamp":1793650812448,"version":"4.5.1"},"reference-count":140,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jaad.2019.08.090","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T01:53:52Z","timestamp":1570586032000},"page":"1045-1058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":478,"title":["Hidradenitis suppurativa"],"prefix":"10.1016","volume":"82","author":[{"given":"Samantha R.","family":"Goldburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Strober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Payette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.08.090_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/exd.13211","article-title":"Should hidradenitis suppurativa\/acne inversa best be renamed as \u201cdissecting terminal hair folliculitis\u201d?","volume":"26","author":"Chen","year":"2017","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.090_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/exd.13849","article-title":"Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017","volume":"28","author":"Shavit","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.7861\/clinmedicine.16-1-70","article-title":"Hidradenitis suppurativa: an update","volume":"16","author":"Ingram","year":"2016","journal-title":"Clin Med"},{"key":"10.1016\/j.jaad.2019.08.090_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1365-2133.2000.03476.x","article-title":"The clinical genetics of hidradenitis suppurativa revisited","volume":"142","author":"Von Der Werth","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/exd.13928","article-title":"Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018","volume":"28","author":"Posso-De Los Rios","year":"2019","journal-title":"Exp Dermatol"},{"issue":"2 pt 1","key":"10.1016\/j.jaad.2019.08.090_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjd.12787","article-title":"The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa","volume":"170","author":"Vinding","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.1988.tb03227.x","article-title":"The symptomatology of hidradenitis suppurativa in women","volume":"119","author":"Jemec","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ad.2011.07.008","article-title":"Epidemiologic study of skin diseases among immigrants in Alicante, Spain [in Spanish]","volume":"103","author":"Albares","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2019.08.090_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaad.2013.06.043","article-title":"Counterpoint: analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States","volume":"69","author":"Sung","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1365-4362.1998.00454.x","article-title":"Skin diseases in Bamako (Mali)","volume":"37","author":"Mah\u00e9","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaad.2012.07.027","article-title":"Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States","volume":"68","author":"Cosmatos","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota","volume":"133","author":"Vazquez","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib16","first-page":"502","article-title":"Incidence of sexual dysfunction among patients with hidradenitis suppurativa: a population-based retrospective analysis","volume":"179","author":"Slyper","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jdv.14686","article-title":"A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP)","volume":"32","author":"Delany","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaad.2018.02.067","article-title":"Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents","volume":"79","author":"Tiri","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1159\/000453259","article-title":"Factors contributing to depression and chronic pain in patients with hidradenitis suppurativa: results from a single-center retrospective review","volume":"232","author":"Vangipuram","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2019.08.090_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","article-title":"Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa","volume":"29","author":"Shavit","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib21","article-title":"Profound consequences of hidradenitis suppurativa: a review","author":"Matusiak","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","article-title":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2340\/00015555-2815","article-title":"Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa","volume":"98","author":"Matusiak","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11916-017-0647-3","article-title":"Pain, psychological comorbidities, disability, and impaired quality of life in hidradenitis suppurativa [corrected]","volume":"21","author":"Patel","year":"2017","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jaad.2019.08.090_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000453355","article-title":"Quality of life and psychosocial implications in patients with hidradenitis suppurativa","volume":"232","author":"Kouris","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2019.08.090_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jdv.14511","article-title":"Factors predicting the self-evaluated health of hidradenitis suppurativa patients recruited from an outpatient clinic","volume":"32","author":"Kjaersgaard Andersen","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib28","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/jdv.14464","article-title":"Recognizing syndromic hidradenitis suppurativa: a review of the literature","volume":"31","author":"Gasparic","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib30","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.jid.2018.06.171","article-title":"Women with hidradenitis suppurativa have an elevated risk of suicide","volume":"138","author":"Tiri","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"3 suppl","key":"10.1016\/j.jaad.2019.08.090_bib31","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.12788\/j.sder.0092","article-title":"Natural history, presentation, and diagnosis of hidradenitis suppurativa","volume":"33","author":"Micheletti","year":"2014","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2019.08.090_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jssdds.2012.06.003","article-title":"Hidradenitis suppurativa (Verneuil's disease)","volume":"17","author":"Dhaou","year":"2013","journal-title":"J Saudi Soc Dermatol Dermatol Surg"},{"key":"10.1016\/j.jaad.2019.08.090_bib33","first-page":"46","article-title":"Hidradenitis suppurativa: epidemiology, clinical features, associated comorbidities and treatment","volume":"152","author":"Shalom","year":"2017","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/ajd.12770","article-title":"Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1","volume":"59","author":"Vekic","year":"2018","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamadermatol.2017.5890","article-title":"A novel severity assessment scoring system for hidradenitis suppurativa","volume":"154","author":"Hessam","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.12788\/j.sder.2017.019","article-title":"Epidemiologic and clinical features of hidradenitis suppurativa","volume":"36","author":"Parulkar","year":"2017","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2019.08.090_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1203475415602840","article-title":"Clinical features and patient outcomes of hidradenitis suppurativa: a cross-sectional retrospective study","volume":"20","author":"Kim","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2019.08.090_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431175","article-title":"Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation","volume":"231","author":"Zouboulis","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2019.08.090_bib39","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/bjd.14038","article-title":"Diagnostic delay in hidradenitis suppurativa is a global problem","volume":"173","author":"Saunte","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib40","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.12688\/f1000research.11337.1","article-title":"Hidradenitis suppurativa: an update on connecting the tracts","volume":"6","author":"Smith","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.jaad.2019.08.090_bib41","series-title":"Dermatologic Surgery, Principles and Practice","first-page":"623","article-title":"Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach","author":"Hurley","year":"1989"},{"key":"10.1016\/j.jaad.2019.08.090_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bjd.17716","article-title":"Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa","volume":"181","author":"Thorlacius","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","article-title":"Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa","volume":"149","author":"Sartorius","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib45","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1365-4632.2010.04545.x","article-title":"A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa","volume":"49","author":"Amano","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib47","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bjd.13270","article-title":"Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib48","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jdv.13216","article-title":"HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study","volume":"30","author":"Kimball","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5 suppl 1","key":"10.1016\/j.jaad.2019.08.090_bib49","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","article-title":"New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes","volume":"73","author":"van der Zee","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib50","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3899\/jrheum.171183","article-title":"Physician's Global Assessment in psoriatic arthritis: a multicenter GRAPPA study","volume":"45","author":"Cauli","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamadermatol.2014.3513","article-title":"Using the Physician Global Assessment in a clinical setting to measure and track patient outcomes","volume":"151","author":"Pascoe","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib52","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/00015555-2513","article-title":"Hurley staging refined: a proposal by the Dutch Hidradenitis Suppurativa Expert Group","volume":"97","author":"Horv\u00e1th","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib54","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/bjd.17508","article-title":"Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment","volume":"180","author":"Rondags","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib55","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1203475419839965","article-title":"Validation of a hidradenitis suppurativa self-assessment tool","volume":"23","author":"Senthilnathan","year":"2019","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2019.08.090_bib56","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1111\/jdv.15276","article-title":"Clinical phenotypes of hidradenitis suppurativa","volume":"33","author":"J\u00f8rgensen","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib57","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jdv.14517","article-title":"Recommendations for the management of comorbidity in hidradenitis suppurativa","volume":"32","author":"Dauden","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3 suppl","key":"10.1016\/j.jaad.2019.08.090_bib59","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.12788\/j.sder.0093","article-title":"Recognizing and managing comorbidities and complications in hidradenitis suppurativa","volume":"33","author":"Menter","year":"2014","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2019.08.090_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib61","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clindermatol.2017.09.007","article-title":"Hidradenitis suppurativa and the metabolic syndrome","volume":"36","author":"Ergun","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5021\/ad.2016.28.2.147","article-title":"Management of hidradenitis suppurativa in patients with metabolic comorbidities","volume":"28","author":"Lim","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jdv.14599","article-title":"Low and high body mass index in hidradenitis suppurativa patients-different subtypes?","volume":"32","author":"Theut Riis","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjd.16261","article-title":"Tobacco smoking and hidradenitis suppurativa: associated disease and an important modifiable risk factor","volume":"178","author":"Micheletti","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib66","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjd.15939","article-title":"Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib67","article-title":"Psoriasis and hidradenitis suppurativa: a large-scale population-based study","author":"Kridin","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib68","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/bjd.16931","article-title":"Incidence of obstructive sleep apnea among patients with hidradenitis suppurativa: a retrospective population-based cohort analysis","volume":"179","author":"Wertenteil","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib69","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.3748\/wjg.v22.i20.4802","article-title":"Hydradenitis suppurativa and inflammatory bowel disease: an unusual, but existing association","volume":"22","author":"Principi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2019.08.090_bib70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/ijd.13932","article-title":"The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014","volume":"57","author":"Ramos-Rodriguez","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib71","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3899\/jrheum.130977","article-title":"Hidradenitis suppurativa associated with spondyloarthritis\u2014results from a multicenter national prospective study","volume":"41","author":"Richette","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.det.2015.08.002","article-title":"Prevalence, risk factors, and comorbidities of hidradenitis suppurativa","volume":"34","author":"Miller","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2019.08.090_bib73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4103\/2229-5178.142517","article-title":"Follicular occlusion tetrad","volume":"5","author":"Vasanth","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2019.08.090_bib74","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/ijd.13603","article-title":"Autoinflammatory syndromes associated with hidradenitis suppurativa and\/or acne","volume":"56","author":"Vinkel","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib75","first-page":"25","article-title":"Cutaneous squamous cell carcinoma complicating hidradenitis suppurativa: a review of the prevalence, pathogenesis, and treatment of this dreaded complication","volume":"27","author":"Chapman","year":"2018","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.jaad.2019.08.090_bib76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/derm.3.1.13900","article-title":"An update on the role of the sebaceous gland in the pathogenesis of acne","volume":"3","author":"Makrantonaki","year":"2011","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.jaad.2019.08.090_bib77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12788\/j.sder.2017.017","article-title":"Pathophysiology of hidradenitis suppurativa","volume":"36","author":"Hoffman","year":"2017","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2019.08.090_bib78","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/apm.12220","article-title":"Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients","volume":"122","author":"Jahns","year":"2014","journal-title":"APMIS"},{"key":"10.1016\/j.jaad.2019.08.090_bib79","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/exd.12098","article-title":"Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology","volume":"22","author":"Melnik","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib80","first-page":"44","article-title":"Finasteride in hidradenitis suppurativa: a \u201cmale\u201d therapy for a predominantly \u201cfemale\u201d disease","volume":"9","author":"Khandalavala","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib81","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"9","author":"Vossen ARJ","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2019.08.090_bib82","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2133.2011.10224.x","article-title":"Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa","volume":"164","author":"Kamp","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib83","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/bjs.1800661206","article-title":"The distribution, size and density of the apocrine glands in hidradenitis suppuritiva","volume":"66","author":"Morgan","year":"1979","journal-title":"Br J Surg"},{"key":"10.1016\/j.jaad.2019.08.090_bib84","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2340\/00015555-2186","article-title":"Increased expression of integrin \u03b16\u03b24 in the basement membrane zone lining the sebaceous glands in hidradenitis suppurativa","volume":"95","author":"Blok","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib85","doi-asserted-by":"crossref","first-page":"325129","DOI":"10.1155\/2014\/325129","article-title":"Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease","volume":"2014","author":"\u015alebioda","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaad.2019.08.090_bib86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/icb.2013.15","article-title":"Regulation of TNF-\u03b1 with a focus on rheumatoid arthritis","volume":"91","author":"Moelants","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaad.2019.08.090_bib87","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/postgradmedj-2015-133419","article-title":"TNF-\u03b1 in a molecularly targeted therapy of psoriasis and psoriatic arthritis","volume":"92","author":"Wcis\u0142o-Dziadecka","year":"2016","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaad.2019.08.090_bib88","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis suppurativa is characterized by dysregulation of the Th17:Treg cell axis, which is corrected by anti-TNF therapy","volume":"137","author":"Moran","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib89","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib90","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.12688\/f1000research.17267.1","article-title":"A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa","volume":"7","author":"Frew","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.jaad.2019.08.090_bib91","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/jdv.14894","article-title":"Insulin resistance in hidradenitis suppurativa: a case-control study","volume":"32","author":"Vilanova","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib92","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjd.15904","article-title":"Adipokines are dysregulated in patients with hidradenitis suppurativa","volume":"178","author":"Malara","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib93","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2019.08.090_bib94","first-page":"667","article-title":"Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy","volume":"164","author":"Shibata","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib95","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00011-017-1074-y","article-title":"The critical role of macrophages in the pathogenesis of hidradenitis suppurativa","volume":"66","author":"Shah","year":"2017","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jaad.2019.08.090_bib96","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bjd.12105","article-title":"Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa","volume":"168","author":"Savva","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib97","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/jdv.15160","article-title":"Anti-TNF-\u03b1 therapy modulates mTORC1 signalling in hidradenitis suppurativa","volume":"33","author":"Balato","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib98","first-page":"413","article-title":"Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?","volume":"179","author":"Kanni","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib99","doi-asserted-by":"crossref","first-page":"e0203672","DOI":"10.1371\/journal.pone.0203672","article-title":"Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature","volume":"13","author":"Hoffman","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2019.08.090_bib100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cyto.2017.12.020","article-title":"Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa","volume":"103","author":"Jim\u00e9nez-Gallo","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.jaad.2019.08.090_bib101","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib102","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2019.08.090_bib103","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2019.0891","article-title":"Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis","author":"Chen","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/13543784.2018.1412430","article-title":"Investigational drugs in clinical trials for hidradenitis suppurativa","volume":"27","author":"Theut Riis","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2019.08.090_bib105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coph.2019.04.006","article-title":"Pharmacological development in hidradenitis suppurativa","volume":"46","author":"Matusiak","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jaad.2019.08.090_bib106","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib107","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00403-017-1769-5","article-title":"IL-36 cytokines are increased in acne and hidradenitis suppurativa","volume":"309","author":"Di Caprio","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2019.08.090_bib108","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.16019","article-title":"Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop","volume":"178","author":"Hessam","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib109","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/jdv.14389","article-title":"Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa","volume":"31","author":"Thomi","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib110","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.7150\/ijbs.4666","article-title":"Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases","volume":"8","author":"Tanaka","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jaad.2019.08.090_bib111","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/ijd.12550","article-title":"Hidradenitis suppurativa: the role of immune dysregulation","volume":"53","author":"Kelly","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib112","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5114\/ada.2017.65626","article-title":"Increased serum interleukin-6 levels in patients with hidradenitis suppurativa","volume":"34","author":"Xu","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jaad.2019.08.090_bib113","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/08820139.2016.1230867","article-title":"Interferon-gamma (IFN-\u03b3) is elevated in wound exudate from hidradenitis suppurativa","volume":"46","author":"Banerjee","year":"2017","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jaad.2019.08.090_bib114","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","article-title":"Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa","volume":"136","author":"Hotz","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib115","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","article-title":"Finasteride for the treatment of hidradenitis suppurativa in children and adolescents","volume":"149","author":"Randhawa","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib116","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2133.1995.tb02663.x","article-title":"Immunohistochemical evidence for differential distribution of 5 alpha-reductase isoenzymes in human skin","volume":"133","author":"Eicheler","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib117","article-title":"Hormonal therapies for hidradenitis suppurativa: review","volume":"23","author":"Clark","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2019.08.090_bib118","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11154-016-9366-z","article-title":"Hidradenitis suppurativa\/acne inversa: an endocrine skin disorder?","volume":"17","author":"Karagiannidis","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jaad.2019.08.090_bib119","first-page":"239","article-title":"The role of androgens and estrogens in hidradenitis suppurativa - a systematic review","volume":"24","author":"Riis","year":"2016","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jaad.2019.08.090_bib120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaad.2016.07.024","article-title":"Menses and pregnancy affect symptoms in hidradenitis suppurativa: a cross-sectional study","volume":"76","author":"Vossen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2018.06.063","article-title":"Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa","volume":"80","author":"Golbari","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib122","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jaad.2017.03.016","article-title":"Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa","volume":"77","author":"Dany","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib123","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.det.2015.07.002","article-title":"The genetics of hidradenitis suppurativa","volume":"34","author":"Ingram","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2019.08.090_bib124","author":"Genetics Home Reference website"},{"key":"10.1016\/j.jaad.2019.08.090_bib125","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/jid.2012.162","article-title":"Mutations in the \u03b3-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa)","volume":"132","author":"Pink","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib126","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jid.2016.04.021","article-title":"High copy numbers of \u03b2-defensin cluster on 8p23.1, confer genetic susceptibility, and modulate the physical course of hidradenitis suppurativa\/acne inversa","volume":"136","author":"Giamarellos-Bourboulis","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib127","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jdermsci.2016.02.009","article-title":"Inflammation-induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients","volume":"82","author":"Hessam","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2019.08.090_bib128","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10753-016-0492-2","article-title":"Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the inflammatory pathway of hidradenitis suppurativa","volume":"40","author":"Hessam","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.jaad.2019.08.090_bib129","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bjd.15007","article-title":"Bacterial biofilm in chronic lesions of hidradenitis suppurativa","volume":"176","author":"Ring","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","article-title":"The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls","volume":"153","author":"Ring","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib131","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/lam.12883","article-title":"Contemporary microbiology and identification of Corynebacteria spp. causing infections in human","volume":"66","author":"Zasada","year":"2018","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.jaad.2019.08.090_bib132","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/21505594.2014.999567","article-title":"Porphyromonas gingivalis virulence factors involved in subversion of leukocytes and microbial dysbiosis","volume":"6","author":"Zenobia","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.jaad.2019.08.090_bib133","doi-asserted-by":"crossref","first-page":"O857","DOI":"10.1111\/1469-0691.12657","article-title":"Bloodstream infections due to Peptoniphilus spp.: report of 15 cases","volume":"20","author":"Brown","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaad.2019.08.090_bib134","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jdv.15183","article-title":"Biofilm production and antibiotic susceptibility of Staphylococcus epidermidis strains from hidradenitis suppurativa lesions","volume":"33","author":"Ardon","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5 suppl 1","key":"10.1016\/j.jaad.2019.08.090_bib135","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jaad.2015.07.041","article-title":"Bacteriology of hidradenitis suppurativa\/acne inversa: a review","volume":"73","author":"Nikolakis","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.08.090_bib136","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/000313481608200423","article-title":"Recalcitrant hidradenitis suppurativa: an investigation of demographics, surgical management, bacterial isolates, pharmacologic intervention, and patient-reported health outcomes","volume":"82","author":"Thomas","year":"2016","journal-title":"Am Surg"},{"key":"10.1016\/j.jaad.2019.08.090_bib137","article-title":"Hidradenitis suppurativa\/acne inversa: a prospective bacteriological study\u00a0of 46 patients and review of the literature","author":"Benzecry","year":"2019","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.08.090_bib138","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/1744666X.2018.1449647","article-title":"An update on the pathogenesis of hidradenitis suppurativa: implications for therapy","volume":"14","author":"Negus","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaad.2019.08.090_bib139","first-page":"1","article-title":"Immunological pathways in hidradenitis suppurativa: current concepts and innovative therapies","volume":"5","author":"Cubilla","year":"2018","journal-title":"Clin Res Dermatol Open Access"},{"key":"10.1016\/j.jaad.2019.08.090_bib140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jdv.15233","article-title":"Hidradenitis suppurativa\/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group","volume":"33","author":"Zouboulis","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219328270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219328270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:52:16Z","timestamp":1759272736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219328270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":140,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0190962219328270"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.090","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(20)30409-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}